IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12226142 B1

PDFFull Text
Date of Patent:
Feb. 18, 2025

Filed:

Aug. 30, 2021

Devices, agents, and associated methods for selective modulation of renal nerves

Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventor:

Robert J. Melder, Santa Rosa, CA (US);

Assignee:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Attorney:

Shumaker & Sieffert, P.A.

Primary Examiner:

Emily L Schmidt

Assistant Examiner:

Samuel J Marrison

Int. Cl.
CPC ...
A61B 18/06 (2006.01); A61K 9/00 (2006.01); A61K 31/165 (2006.01); A61K 47/64 (2017.01); A61M 37/00 (2006.01); A61P 13/12 (2006.01); A61P 25/00 (2006.01); A61B 18/00 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61B 18/06 (2013.01); A61K 9/0019 (2013.01); A61K 9/0034 (2013.01); A61K 31/165 (2013.01); A61K 47/64 (2017.08); A61M 37/00 (2013.01); A61P 13/12 (2018.01); A61P 25/00 (2018.01); C12Y 302/01017 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61M 2025/1015 (2013.01); A61M 2025/1052 (2013.01);
Abstract

Devices, agents, and associated methods for selective modulation of renal nerves by localized delivery of neural ablative substances are disclosed herein. One aspect of the present technology is directed to a method for delivering a neuromodulatory agent (e.g., capsaicin) via a catheter to a kidney of the patient. The neuromodulatory agent selectively neuromodulates afferent renal nerves in a patient compared efferent renal nerves of the patient. The method can also include removing the catheter from the patient after delivering the neuromodulatory agent to conclude the procedure.

Find Patent Forward Citations

Loading…